Background: Psycho-oncology literature has shown that 30–50% of cancer patients meet the criteria for a psychiatric diagnosis, according to the usual nosographic classification (e.g. DSM). The Diagnostic Criteria for Psychosomatic Research (DCPR) have been shown to be useful in identifying psychological constellations in patients with medical illness. The aims of the study were to compare the DSM-IV and the DCPR in their application to cancer patients. Method: One hundred and forty-six patients with cancer underwent semistructured interviews to assess psychiatric morbidity and psychosocial syndromes according to the DSM-IV and the DCPR, respectively. The Brief Symptom Inventory (BSI) was also used to assess psychological stress symptoms. Results: Sixty-five subjects (44.5%) met the criteria for a DSM-IV diagnosis (DSM cases), while 104 patients (71.2%) presented symptoms meeting the criteria for at least one DCPR syndrome. Three DCPR dimensions were more frequent than others, specifically Health Anxiety (37.7%), Demoralization (28.8%) and Alexithymia (26%). Among the subjects with no formal DSM-IV diagnosis (n = 81), 58% had at least one DCPR syndrome. DSM-IV cases had higher scores on several BSI subscales in comparison with patients with only one DCPR syndrome, while no difference was found in patients with more than one DCPR diagnosis. Conclusions: The DCPR system was found to be useful in oncology in investigating psychological conditions which are not identified by the DSM-IV alone. Assessment of more specific constructs, other than intensity of general stress symptoms, may give more specific information and help in tailoring psychological intervention for patients with cancer.

Keywords:
Diagnostic Criteria for Psychosomatic Research, Psychiatric morbidity, Cancer
1.
van’t Spijker A, Trijsburg RW, Duivenvoorden HJ: Psychological sequelae of cancer diagnosis: A meta-analytical review of 58 studies after 1980. Psychosom Med 1997;59:280–293.
2.
Breitbart W: Identifying patients at risk for, and treatment of major psychiatric complications of cancer. Support Care Cancer 1995;3:45–60.
3.
Grassi L, Indelli M, Marzola M, Maestri A, Santini A, Piva E, Boccalon M: Depression and quality of life in home care assisted cancer patients. J Pain Sympt Manage 1996;12:300–307.
4.
Spiegel D, Sands S, Koopman C: Pain and depression in patients with cancer. Cancer 1994;74:2570–2578.
5.
Henrikkson MM, Isometsä ET, Hietanen PS, Aro HM, Lönqvist JK: Mental disorders in cancer suicides. J Affect Dis 1995;36:11–20.
6.
Saleeba A, Weitzner MA, Meyers CA: Subclinical psychological distress in long-term survivors of breast cancer: A preliminary communication. J Psychosoc Oncol 1996;14:83–93.
7.
Holzner B, Kemmler G, Kopp M, Moschen R, Schweigkofler H, Dunser M, Margreiter R, Fleischhacker WW, Sperner-Unterweger B: Quality of life in breast cancer patients – not enough attention for long-term survivors? Psychosomatics 2001;42:117–123.
8.
Grassi L, Rosti G, Albieri G, Marangolo M: Depression and abnormal illness behavior in cancer patients. Gen Hosp Psychiatry 1989;11:404–411.
9.
Grassi L, Rosti G: Psychiatric and psychosocial concomitants of abnormal illness behaviour in patients with cancer. Psychother Psychosom 1996;65:246–252.
10.
Grassi L, Rosti G: Psychiatric morbidity among long-term survivors of cancer. A six-year follow-up study. Psychosomatics 1996;37:523–532.
11.
Fava GA: Beyond the biopsychosocial model: Psychological characterization of medical illness. J Psychosom Res 1996;40:117–120.
12.
Fava GA, Mangelli L, Ruini C: Assessment of psychological distress in the setting of medical disease. Psychother Psychosom 2001;70:171–175.
13.
Fava GA, Freyberger HJ, Bech P, Christodoulou G, Sensky T, Theorell T, Wise TN: Diagnostic criteria for use in psychosomatic research. Psychother Psychosom 1995;63:1–8.
14.
Porcelli P, De Carne M, Fava GA: Assessing somatization in functional gastrointestinal disorders: Integration of different criteria. Psychother Psychosom 2000;69:198–204.
15.
Sonino N, Navarrini C, Ruini C, Ottolini F, Paoletta A, Fallo F, Boscaro M, Fava GA: Persistent psychological distress in patients treated for endocrine disease. Psychother Psychosom 2004;73:78–83.
16.
Grandi S, Fabbri S, Tossani E, Mangelli L, Branzi A, Magelli C: Psychological evaluation after cardiac transplantation: The integration of different criteria. Psychother Psychosom 2001;70:176–183.
17.
Rafanelli C, Roncuzzi R, Finos L, Tossani E, Tomba E, Mangelli L, Urbinati S, Pinelli G, Fava GA: Psychological assessment in cardiac rehabilitation. Psychother Psychosom 2003;72:343–349.
18.
Porcelli P, De Carne M, Todarello O: The prediction of treatment outcome of patients with functional gastrointestinal disorders by the diagnostic criteria for psychosomatic research (DCPR). Psychother Psychosom 2004;73:166–173.
19.
Zabora J, Brintzenhofe-Szoc K, Jacobsen P, Curbow B, Piantadosi S, Hooker C, Owens A, Derogatis L: A new psychosocial screening instrument for use with cancer patients. Psychosomatics 2001;42:241–246.
20.
Payne DK, Hoffman RG, Theodulou M, Dosik M, Massie MJ: Screening for anxiety and depression in women with breast cancer. Psychosomatics 1999;40:64–69.
21.
Moorey S, Greer S, Watson M, Gorman C, Rowden L, Tunmore R, Robertson B, Bliss J: The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer. Br J Psychiatry 1991;158:255–259.
22.
Hopwood P, Howell A, Maguire P: Screening for psychiatric morbidity in patients with advanced breast cancer: Validation of two self-report questionnaire. Br J Cancer 1991;64:353–356.
23.
Hall A, A’Hern R, Fallowfield L: Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer? Eur J Cancer 1999;35:79–85.
24.
Karnofsky DA, Burchenal JH: The clinical evaluation of chemotherapeutic agents in cancer; in MacLeod CM (ed): Evaluation of Chemotherapeutic Agents. New York, Columbia University Press, 1949, pp 191–205.
25.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, DSM IV, ed 4. Washington, American Psychiatric Association, 1994.
26.
Mangelli L, Rafanelli C, Porcelli P, Fava GA: Interview for the Diagnostic Criteria of Psychosomatic Research (DCPR). Psychother Psychosom 2003;72:346–348.
27.
Derogatis LR, Spencer PM: The Brief Symptom Inventory (BSI). Administration, Scoring and Procedures Manual-I. Towson, Clinical Psychometric Research, 1982.
28.
Norusis MJ: Statistical Package for the Social Sciences (SPSS) Professional Statistics-6.1. Chicago, SPSS, 1994.
29.
Grassi L, Rosti G, Lasalvia A, Marangolo M: Psychosocial variables associated with mental adjustment to cancer. Psychooncology 1993;2:11–20.
30.
Watson M, Haviland JS, Greer S, Davidson J, Bliss JM: Influence of psychological response on survival in breast cancer: A population-based cohort study. Lancet 1999;354:1331–1336.
31.
Brown KW, Levy AR, Rosberger Z, Edgar L: Psychological distress and cancer survival: A follow-up of 10 years after diagnosis. Psychosom Med 2003:65:636–643.
32.
Denollet J: Personality and coronary heart disease: The Type D Scale-16 (DS16). Ann Behav Med 1998;20:209–215.
33.
Denollet J, Sys SU, Stroobant N, Rombouts H, Gillebert TC, Brutsaert DL: Personality as independent predictor of long-term mortality in patients with coronary heart disease. Lancet 1996;347:417–421.
34.
Denollet J: Personality and risk of cancer in men with coronary heart disease. Psychol Med 1998;28:991–995.
35.
Angelino AF, Treisman GJ: Major depression and demoralization in cancer patients: Diagnostic and treatment considerations. Support Care Cancer 2001;9:344–349.
36.
Clarke DM, Kissane DW: Demoralization: Its phenomenology and importance. Aust NZ J Psychiatry 2002;36:733–742.
37.
Gil S, Gilbar O: Hopelessness among cancer patients. J Psychosoc Oncol 2001;19:21–33.
38.
Everson SA, Goldberg DE, Kaplan GA, Cohen RD, Pukkala E, Tuomilheto J, Salonen JT: Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med 1996;58:113–121.
39.
Kissane DW: Demoralisation: Its impact on informed consent and medical care. MJA 2001;175:537–539.
40.
Chaturvedi SK, Maguire GP: Persistent somatization in cancer: A controlled follow-up study. J Psychosom Res 1998;45:249–256.
41.
Kissane DW, Clarke DM, Street AF: Demoralization syndrome. A relevant psychiatric diagnosis for palliative care. J Palliat Care 2001;17:12–21.
42.
Porcelli P, De Carne M: Criterion-related validity of the diagnostic criteria for psychosomatic research for alexithymia in patients with functional gastrointestinal disorders. Psychother Psychosom 2001;70:184–188.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.